EelsTide® Eel Bone Peptides

EelsTide® is an innovative nutritional ingredient brand developed by CIIMBIO (Suzhou) Co., Ltd., and officially registered in both China and the United States. It originates from Muraenesox cinereus (star conger eel) bones and is the result of a collaborative technology transfer with Shenzhen University. Protected by a Chinese invention patent, EelsTide® is produced with a unique combination enzymatic hydrolysis process under strict national standards, ensuring high-quality, bioactive peptides.

Extensive preclinical studies have confirmed its promising health benefits. Compared with established nutrients such as undenatured type II collagen, chondroitin sulfate, and glucosamine, EelsTide® has demonstrated strong efficacy in repairing cartilage injury, enhancing immune response, and reducing fatigue. Its multifunctional effects highlight its potential as a new-generation solution for bone and joint health. Human clinical trials are currently in preparation to further validate safety and effectiveness.

Beyond individual health benefits, EelsTide® represents a breakthrough in the sustainable use of aquaculture resources. By converting eel bones—an underutilized byproduct of aquaculture—into functional peptides, it bridges the aquatic processing industry with the functional food sector. This dual value not only reduces waste but also drives innovation across industries, contributing to both environmental responsibility and nutritional science.

In today’s context of rising skeletal problems among younger populations, the mainstreaming of fitness lifestyles, and the global challenge of aging societies, bone health has become a critical issue. EelsTide® offers a safe, natural, non-pharmaceutical approach to strengthening the body, improving skeletal function, and supporting long-term wellness. With its combination of scientific precision, patented technology, and sustainable vision, EelsTide® is poised to become a leading force in global bone health management and healthy aging solutions.